JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Obara, Y.
Right arrow Articles by Ohizumi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Obara, Y.
Right arrow Articles by Ohizumi, Y.

Vol. 301, Issue 3, 803-811, June 2002

beta -Eudesmol Induces Neurite Outgrowth in Rat Pheochromocytoma Cells Accompanied by an Activation of Mitogen-Activated Protein Kinase

Yutaro Obara, Takashi Aoki, Masayoshi Kusano and Yasushi Ohizumi

Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai, Japan

beta -Eudesmol, a sesquiterpenoid isolated from "So-jutsu" (Atractylodis lanceae rhizomas), is known to have various unique effects on the nervous system. We examined in detail the mechanism by which beta -eudesmol modified neuronal function using rat pheochromocytoma cells (PC-12). beta -Eudesmol at concentrations of 100 and 150 µM significantly induced neurite extension in PC-12 cells, which was accompanied, at the highest concentration, by suppression of [3H]thymidine incorporation. beta -Eudesmol at concentrations of 100 and 150 µM also evoked a significant increase in intracellular Ca2+ concentration ([Ca2+]i) in these cells, as determined by the fura 2 assay. Much of this increase remained even after the extracellular Ca2+ was chelated by EGTA. The [Ca2+]i increase induced by beta -eudesmol was partially inhibited by the phosphoinositide-specific phospholipase C (PI-PLC) inhibitor 1-[6-[[17beta -methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122) (2 µM) under extracellular Ca2+-free conditions. Furthermore, beta -eudesmol, in a concentration-dependent fashion, caused an accumulation of inositol phosphates. beta -Eudesmol (150 µM) promoted phosphorylation of both mitogen-activated protein kinase (MAPK) and cAMP-responsive element binding protein in a time-dependent manner. These phosphorylations were suppressed by the MAPK kinase inhibitor 2-(2'-amino-3'-methoxyphenol)-oxanaphthalen-4-one (PD98059) (50 µM), U-73122 (2 µM), the calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W7) (1-10 µM), and the protein kinase A inhibitor N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89) (1-10 µM). beta -Eudesmol-induced neurite extension was significantly inhibited by both U-73122 (2 µM) and PD98059 (30 µM), suggesting the involvement of PI-PLC and MAPK in neurite outgrowth. beta -Eudesmol, being a small molecule, may therefore be a promising lead compound for potentiating neuronal function. Furthermore, the drug may be useful in helping to clarify the mechanisms underlying neuronal differentiation.


0022-3565/02/3013-0803$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al.
Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Nakajima, T. Yamakuni, K. Matsuzaki, N. Nakata, H. Onozuka, A. Yokosuka, Y. Sashida, Y. Mimaki, and Y. Ohizumi
Nobiletin, a Citrus Flavonoid, Reverses Learning Impairment Associated with N-Methyl-D-aspartate Receptor Antagonism by Activation of Extracellular Signal-Regulated Kinase Signaling
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 784 - 790.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.